Silvercrest Asset Management Group LLC Ionis Pharmaceuticals Inc Transaction History
Silvercrest Asset Management Group LLC
- $14.6 Billion
- Q4 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 6,617 shares of IONS stock, worth $188,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,617Holding current value
$188,650% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
407Shares Held
131MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$470 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$404 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$327 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$294 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$224 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.05B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...